Frontlight ResearchEarly access
Trial site
University of Utah Health Sciences Center
- 5running trials
- 5closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis4 trials
- Alzheimer disease1 trial
- Chronic kidney disease1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Heart failure1 trial
- Lupus (SLE)1 trial
- Obesity1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Boehringer Ingelheim4 trials
- Biogen2 trials
- University of Utah2 trials
- Rohit Aggarwal, MD1 trial
- Vicore Pharma AB1 trial
Running trials
Not yet recruiting
Active, not recruiting
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Active, not recruiting
Active, not recruiting
Recruiting
Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Site data: ClinicalTrials.govUpdated 19 Nov 2026